2Turktasl,Gokcoran,Demirsoys,et al.The association of chronicurticaria and angio edema with autoimmune thyroiditis[J].Int JDjdermatol,1997,36(3):187-190.
1[1]Prakash A, Lamb HM.. Mizolastine: A review of its use in allergic rhinitis and chronic idiopathic urticaria[J]. Biodrug,1998, 10(1):42-59.
2[2]Scadding GK, Tasman AJ, Murrieta-Aguttes M, et al. Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis[J]. J Int Med Res, 1999, 27(6):273-285.
3[3]Wedi B, Novacovic V,Koemer M, et al. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitory effects of antiinflammatory drugs[J]. J Allergy Clin Immunol, 2000,105(3):552-560.
4[4]Pichat P, Angel I, Arbilla S. Anti-inflammatory properties of Mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat [J]. Arzneim-Forsch / Drug Res .1998, 48(1):173-178.
5[5]Simons FER, Simons LJ. Clinical pharmacology of new histamine H1 receptor antagonists[J]. Clin Pharmacokinet, 1999, 36(5): 329-352.
2Nijmeijer S, Leurs R, Vischer H F. Constitutive activity of the hista- mine H( 1 ) receptor[ J ]. Methods Enzymol,2010,484: 127 - 147.
3Mizuguchi H, Ono S, Hattori M, et al. Inverse agonistic activity of anti- histamines and suppression of histamine Hi receptor gene expression [J]. J Pharmacol Sci,2012,118(1) : 117 -21.
4Tanizaki H, Ikoma A, Fukuoka M, et al. Effects of bepotastine and fexofenadine on histamine -induced flare, wheal and itch[ J]. Int Arch Allergy Immunol,2012,158 (2) : 191 - 195.
5Scaglione F. Safety profile of bilastine: 2rid generation H1 - antihista- mines[J]. Eur Rev Med Pharmacol Sci,2012,16(14) : 1999 -2005.
